Brian H. Nathanson, PhD

CEO
OptiStatim, LLP

Poster(s):

• (537) Comparative Effectiveness of Meropenem/Vaborbactam vs Ceftazidime/Avibactam in Hospital Pneumonia
  Monday, January 22, 2024

  11:30 AM – 12:30 PM MT